Ticarcillin

Ticarcillin

Clinical data
Pregnancy category	AU: B2 US: B (No risk in non-human studies)
Routes of administration	Intravenous
ATC code	J01CA13 (WHO) J01CR03 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding	45%
Elimination half-life	1.1 hours
Excretion	Renal
Identifiers
IUPAC name (2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-yl- acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo[3.2.0]heptane-2-carboxylic acid
CAS Number	34787-01-4
PubChem CID	36921
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H16N2O6S2
Molar mass	384.429 g/mol

WikiDoc Resources for Ticarcillin
Articles
Most recent articles on Ticarcillin Most cited articles on Ticarcillin Review articles on Ticarcillin Articles on Ticarcillin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ticarcillin Images of Ticarcillin Photos of Ticarcillin Podcasts & MP3s on Ticarcillin Videos on Ticarcillin
Evidence Based Medicine
Cochrane Collaboration on Ticarcillin Bandolier on Ticarcillin TRIP on Ticarcillin
Clinical Trials
Ongoing Trials on Ticarcillin at Clinical Trials.gov Trial results on Ticarcillin Clinical Trials on Ticarcillin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ticarcillin NICE Guidance on Ticarcillin NHS PRODIGY Guidance FDA on Ticarcillin CDC on Ticarcillin
Books
Books on Ticarcillin
News
Ticarcillin in the news Be alerted to news on Ticarcillin News trends on Ticarcillin
Commentary
Blogs on Ticarcillin
Definitions
Definitions of Ticarcillin
Patient Resources / Community
Patient resources on Ticarcillin Discussion groups on Ticarcillin Patient Handouts on Ticarcillin Directions to Hospitals Treating Ticarcillin Risk calculators and risk factors for Ticarcillin
Healthcare Provider Resources
Symptoms of Ticarcillin Causes & Risk Factors for Ticarcillin Diagnostic studies for Ticarcillin Treatment of Ticarcillin
Continuing Medical Education (CME)
CME Programs on Ticarcillin
International
Ticarcillin en Espanol Ticarcillin en Francais
Business
Ticarcillin in the Marketplace Patents on Ticarcillin
Experimental / Informatics
List of terms related to Ticarcillin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ticarcillin is a carboxypenicillin. It is almost invariably sold and used in combination with clavulanate as Timentin®. Because it is a penicillin, it also falls within the larger class of beta-lactam antibiotics. Its main clinical use is as an injectable antibiotic for the treatment of gram negative bacteria, in particular, Pseudomonas aeruginosa.

Chemically, ticarcillin is C₁₅H₁₆N₂O₆S₂ (CAS number 34787-01-4). It is provided as a white or pale yellow powder. It is highly soluble in water, but should only be dissolved immediately before use to prevent degradation.

Mechanism of Action

Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis when the bacteria tries to divide, causing death.

Ticarcillin is similar to penicilin in that it contains a β-lactam ring. This can lead to resistance in bacteria containing β-lactamase, which cleaves the ring and inactivates it. It is often paired with a β-lactamase inhibitor such as clavulanic acid. Because of ticarcillins similarties to penicillin, including the β-lactam ring, it can cause similar allergic reactions in patients sensitive to penicillin.

Other Uses

In molecular biology, ticarcillin is used to as an alternative to ampicillin to test the uptake of marker genes into bacteria. It prevents the appearance of satellite colonies that occur when ampicillin breaks down in the media. It is also used in plant molecular biology to kill agrobacterium, which is used to deliver genes to plant cells.

Dosing and Posology

Ticarcillin is not absorbed orally, and therefore must be given by intravenous or intramuscular injection. The usual adult dose of Timentin is 3.5g four times a day.

Trade Names and Preparations

• Ticarcillin: Ticar® (Formerly marketed by Beecham, then SmithKline Beecham until 1999, when it merged with Glaxo to form GlaxoSmithKline; no longer available in the UK. US distribution ceased in 2004. Ticar was replaced by Timentin.)
  
  
• Ticarcillin/clavulanate: Timentin® (UK and US, marketed by Beecham, then GlaxoSmithKline).